Regenerative Therapy
Technology Platform
Autologous Tissue Engineering
At AscentX Medical, our technology platform is at the forefront of regenerative therapy. We specialize in advanced tissue engineering techniques that leverage the body’s natural ability to heal itself. Our innovative approach focuses on autologous tissue engineering, where injectable microspheres are used to stimulate the growth of the body´s own tissue, minimizing the risk of rejection and maximizing the effectiveness of treatments.
Tissue Engineering
Injectable Regenerative Therapy
Our regenerative therapy is an injectable solution with our proprietary formulation of non-resorbable PMMA (Polymethylmethacrylate) microspheres suspended in bovine collagen. PMMA is one of the safest and most biocompatible polymers, widely used in ophthalmic, orthopedic, and dental applications due to its excellent biocompatibility. The microspheres act as bio-stimulants, encouraging the patient’s body to regenerate its own collagen and tissues. This results in therapeutic outcomes that are natural and long-lasting, with studies demonstrating efficacy lasting upwards of 10 years.
This advanced tissue engineering solution creates a scaffold that supports the growth of new, healthy tissue. When injected, our formulation stimulates fibroblasts and the deposition of autologous collagen, resulting in robust, vascularized tissue that restores both function and appearance.
Our technology is designed to address a variety of medical conditions such as aging skin, stress urinary incontinence (SUI), fecal incontinence (FI), vocal cord paralysis (VCP), and gastro-esophageal reflux (GERD) that result from atrophy, relaxation, and the loss of tissue volume, elasticity, and function. By harnessing the power of autologous tissue engineering, we offer treatments that not only alleviate symptoms but also provide long-lasting, regenerative solutions.
BENEFITS
Benefits of Our Technology
At AscentX Medical, our technology platform offers numerous benefits that set us apart in the field of regenerative therapy. By leveraging our injectable microspheres and autologous tissue engineering techniques, we provide innovative solutions that deliver significant advantages for patients and healthcare providers alike.
- Long-Lasting Results: Our regenerative therapy stimulates and promotes the growth of new, healthy tissue with injectable microspheres. This approach ensures long-lasting results, as the newly formed tissue is robust and integrated seamlessly into the body.
- Reduced Risk of Rejection: By utilizing autologous tissue engineering, we minimize the risk of immune rejection. Since the therapy stimulates the growth of patient’s own cells, the body is less likely to react negatively, enhancing the safety and effectiveness of the treatment.
- Minimally Invasive: Our injectable therapies are designed to be minimally invasive, reducing recovery times and associated risks compared to traditional surgical procedures. Patients can benefit from effective treatments with less downtime and fewer complications.
- Versatility: Our technology can address a wide range of medical conditions resulting from tissue volume, elasticity, and function loss. This versatility makes our solutions applicable to various therapeutic areas, improving patient outcomes across multiple disciplines.
- Enhanced Quality of Life: By restoring tissue function and appearance, our treatments significantly improve patients’ quality of life. Whether addressing aesthetic concerns or medical conditions, our technology helps patients regain confidence and enjoy better health outcomes.
Tissue Engineering
Pipeline Products
Services
Contract Manufacturing Organization (CMO)
Aseptic Fill and Finish Services For the Pharmaceutical and Medical Device Industries
Literature